Studies Comparing PCI Versus CABG for Left Main CAD e673 3.7.3. Revascularization Considerations for Left Main CAD e674 3.8. Proximal LAD Artery Disease e674 3.9. Clinical Factors That May Influence the Choice of Revascularization e674 3.9.1. Diabetes Mellitus e674 3.9.2. Chronic Kidney Disease e675 3.9.3. Completeness of Revascularization e675 3.9.4. LV Systolic Dysfunction e675 3.9.5. Previous CABG e675 3.9.6. Unstable Angina/Non ST-Elevation Myocardial Infarction e676 3.9.7. DAPT Compliance and Stent Thrombosis: Recommendation e676 3.10. TMR as an Adjunct to CABG e676 3.11. Hybrid Coronary Revascularization: Recommendations e676 4. Perioperative Management e677 4.1. Preoperative Antiplatelet Therapy: Recommendations e677 4.2. Postoperative Antiplatelet Therapy: Recommendations e677 4.3. Management of Hyperlipidemia: Recommendations e678 4.3.1. Timing of Statin Use and CABG Outcomes e679 4.3.1.1. Potential Adverse Effects of Perioperative Statin Therapy e679 4.4. Hormonal Manipulation: Recommendations e679 4.4.1. Glucose Control e679 4.4.2. Postmenopausal Hormone Therapy e680 4.4.3. CABG in Patients With Hypothyroidism e680 4.5. Perioperative Beta Blockers: Recommendations e680 4.6. ACE Inhibitors/ARBs: Recommendations e681 4.7. Smoking Cessation: Recommendations e682 4.8. Emotional Dysfunction and Psychosocial Considerations: Recommendation e683 4.8.1. Effects of Mood Disturbance and Anxiety on CABG Outcomes e683 4.8.2. Interventions to Treat Depression in CABG Patients e683 4.9. Cardiac Rehabilitation: Recommendation e683 4.10. Perioperative Monitoring e684 Hillis et al 2011 ACCF/AHA CABG Guideline e653 4.10.1. Electrocardiographic Monitoring: Recommendations e684 4.10.2. Pulmonary Artery Catheterization: Recommendations e684 4.10.3. Central Nervous System Monitoring: Recommendations e684 5. CABG-Associated Morbidity and Mortality: Occurrence and Prevention e685 5.1. Public Reporting of Cardiac Surgery Outcomes: Recommendation e685 5.1.1. Use of Outcomes or Volume as CABG Quality Measures: Recommendations e686 5.2. Adverse Events e687 5.2.1. Adverse Cerebral Outcomes e687 5.2.1.1. Stroke e687 5.2.1.1.1. Use of Epiaortic Ultra- sound Imaging to Reduce Stroke Rates: Recom- mendation e687 5.2.1.1.2. The Role of Preoperative Carotid Artery Noninva- sive Screening in CABG Patients: Recommenda- tions e687 5.2.1.2. 